1g versus 2 g daily intravenous ceftriaxone in the treatment of community onset pneumonia - a propensity score analysis of data from a Japanese multicenter registry.

Shinya HasegawaRyuichi SadaMakito YaegashiKonosuke MorimotoTakahiro Morinull null

Published in: BMC infectious diseases (2019)

The propensity score-matched analysis of multicenter cohort data from Japan revealed that the cure rate for COP patients treated with 1 g daily CRO was non-inferior to that of patients treated with 2 g daily CRO.

Keyphrases

physical activity
electronic health record
big data
cross sectional
healthcare
double blind
mental health
high dose
clinical trial
single cell
machine learning
intensive care unit
combination therapy
respiratory failure